Literature DB >> 11058597

IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1.

J Lee1, W H Ho, M Maruoka, R T Corpuz, D T Baldwin, J S Foster, A D Goddard, D G Yansura, R L Vandlen, W I Wood, A L Gurney.   

Abstract

We report identification of interleukin (IL)-17E, a novel member of the IL-17 family of cytokines. IL-17E is a ligand for the recently identified protein termed EVI27/IL-17BR, which we term IL-17 receptor homolog 1 (IL-17Rh1) in light of the multiple reported ligand-receptor relationships. Murine EVI27 was identified through its location at a common site of retroviral integration in BXH2 murine myeloid leukemias. IL-17Rh1 shows highest level expression in kidney with moderate expression in multiple other organs, whereas IL-17E mRNA was detected at very low levels in several peripheral tissues. IL-17E induces activation of NF-kappaB and stimulates production of the proinflammatory chemokine IL-8.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11058597     DOI: 10.1074/jbc.M008289200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  111 in total

1.  Signal peptide prediction based on analysis of experimentally verified cleavage sites.

Authors:  Zemin Zhang; William J Henzel
Journal:  Protein Sci       Date:  2004-08-31       Impact factor: 6.725

Review 2.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 3.  IL-17 family member cytokines: regulation and function in innate immunity.

Authors:  Joseph M Reynolds; Pornpimon Angkasekwinai; Chen Dong
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-11       Impact factor: 7.638

Review 4.  IL-17A-producing neutrophil-regulatory Tn lymphocytes.

Authors:  Klaus Ley; Emily Smith; Matthew A Stark
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells.

Authors:  Saori Furuta; Yung-Ming Jeng; Longen Zhou; Lan Huang; Irene Kuhn; Mina J Bissell; Wen-Hwa Lee
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

6.  Critical role of IL-25 in nematode infection-induced alterations in intestinal function.

Authors:  Aiping Zhao; Joseph F Urban; Rex Sun; Jennifer Stiltz; Motoko Morimoto; Luigi Notari; Kathleen B Madden; Zhonghan Yang; Viktoriya Grinchuk; Thirumalai R Ramalingam; Thomas A Wynn; Terez Shea-Donohue
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

7.  Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.

Authors:  Rolf E Kuestner; David W Taft; Aaron Haran; Cameron S Brandt; Ty Brender; Karen Lum; Brandon Harder; Shannon Okada; Craig D Ostrander; James L Kreindler; Shean J Aujla; Brian Reardon; Margaret Moore; Pamela Shea; Randall Schreckhise; Thomas R Bukowski; Scott Presnell; Patricia Guerra-Lewis; Julia Parrish-Novak; Jeff L Ellsworth; Stephen Jaspers; Katherine E Lewis; Mark Appleby; Jay K Kolls; Mark Rixon; James W West; Zeren Gao; Steven D Levin
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

8.  Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Authors:  Tímea Mosolygó; József Korcsik; Emese Petra Balogh; Ildikó Faludi; Dezső P Virók; Valéria Endrész; Katalin Burián
Journal:  Inflamm Res       Date:  2013-02-06       Impact factor: 4.575

Review 9.  IL-17RC: a partner in IL-17 signaling and beyond.

Authors:  Allen W Ho; Sarah L Gaffen
Journal:  Semin Immunopathol       Date:  2009-12-13       Impact factor: 9.623

10.  The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.

Authors:  Tomiyasu Arisawa; Tomomitsu Tahara; Tomoyuki Shibata; Mitsuo Nagasaka; Masakatsu Nakamura; Yoshio Kamiya; Hiroshi Fujita; Masahiko Nakamura; Daisuke Yoshioka; Yuko Arima; Masaaki Okubo; Ichiro Hirata; Hiroshi Nakano
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.